# Synovics Pharmaceuticals, Inc. (SYVC)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/SYVC/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2009 | $ 16.99M | $ -8.65M | $ 985.9K | $ 4.54M | $ -773.0K |
| 2008 | $ 39.31M | $ -6.07M | $ 4.78M | $ 6.55M | $ 5.00M |
| 2007 | $ 35.33M | $ -31.58M | $ -6.65M | $ 18.75M | $ -8.10M |
| 2006 | $ 15.92M | $ -12.98M | $ -10.23M | $ 17.87M | $ 13.10M |
| 2005 | $ 12.4K | $ -4.41M | $ -3.78M | $ 4.30M | $ 11.30M |
| 2004 | $ 149.5K | $ -1.70M | $ -990.1K | $ 0 | $ 904.6K |
| 2002 | $ 55.3K | $ -2.78M | $ -1.13M | N/A | $ -774.6K |
| 2001 | $ 57.0K | $ -4.28M | $ -2.56M | $ 583.0K | $ 982.2K |
| 2000 | $ 203.0K | $ -3.89M | $ -2.82M | $ 902.3K | $ 1.88M |
| 1999 | $ 4.74M | $ -8.51M | $ -5.26M | $ 333.8K | $ 3.14M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -5.87 |
| Liabilities / Eq | -25.28 |
| Current Ratio | 0.27 |

## Other views

- [Metrics](https://sponda.capital/en/SYVC.md)
- [Charts](https://sponda.capital/en/SYVC/charts.md)
- [Compare](https://sponda.capital/en/SYVC/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.